European Medicines Agency to review morning after pill, drug may work less well in heavy women

LONDON – The European Medicines Agency says it has started a review of emergency contraceptives to see if they are less effective in overweight women.

In November, French drug maker HRA Pharma announced its morning-after pill didn’t work in women heavier than 80 kilograms (176 pounds) and changed its labels to warn patients after consulting with European regulators.

In a statement on Friday, the EMA said it would evaluate new data suggesting that a high body weight could compromise the effectiveness of the morning-after pill.

HRA Pharma’s Norlevo contains levonorgestrel, the same active ingredient in other medicines including ellaOne, Levonnelle and Levodonna.

The morning-after pill can be taken up to 72 hours after unprotected sex. It works by preventing ovulation or fertilization of an egg.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.